Literature DB >> 21934409

Cysteinyl leukotrienes impair hypoxic pulmonary vasoconstriction in endotoxemic mice.

Bodil Petersen1, K Frank Austen, Kenneth D Bloch, Yukako Hotta, Fumito Ichinose, Yoshihide Kanaoka, Warren M Zapol.   

Abstract

BACKGROUND: Sepsis impairs hypoxic pulmonary vasoconstriction (HPV) in patients and animal models, contributing to systemic hypoxemia. Concentrations of cysteinyl leukotrienes are increased in the bronchoalveolar lavage fluid of patients with sepsis, but the contribution of cysteinyl leukotrienes to the impairment of HPV is unknown.
METHODS: Wild-type mice, mice deficient in leukotriene C(4) synthase, the enzyme responsible for cysteinyl leukotriene synthesis, and mice deficient in cysteinyl leukotriene receptor 1 were studied 18 h after challenge with either saline or endotoxin. HPV was measured by the increase in left pulmonary vascular resistance induced by left mainstem bronchus occlusion. Concentrations of cysteinyl leukotrienes were determined in the bronchoalveolar lavage fluid.
RESULTS: In the bronchoalveolar lavage fluid of all three strains, cysteinyl leukotrienes were not detectable after saline challenge; whereas endotoxin challenge increased cysteinyl leukotriene concentrations in wild-type mice and mice deficient in cysteinyl leukotriene receptor 1, but not in mice deficient in leukotriene C(4) synthase. HPV did not differ among the three mouse strains after saline challenge (120 ± 26, 114 ± 16, and 115 ± 24%, respectively; mean ± SD). Endotoxin challenge markedly impaired HPV in wild-type mice (41 ± 20%) but only marginally in mice deficient in leukotriene C(4) synthase (96 ± 16%, P < 0.05 vs. wild-type mice), thereby preserving systemic oxygenation. Although endotoxin modestly decreased HPV in mice deficient in cysteinyl leukotriene receptor 1 (80 ± 29%, P < 0.05 vs. saline challenge), the magnitude of impairment was markedly less than in endotoxin-challenged wild-type mice.
CONCLUSION: Cysteinyl leukotrienes importantly contribute to endotoxin-induced impairment of HPV in part via a cysteinyl leukotriene receptor 1-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934409      PMCID: PMC3194098          DOI: 10.1097/ALN.0b013e31822e94bd

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  47 in total

Review 1.  Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases.

Authors:  R A Lewis; K F Austen; R J Soberman
Journal:  N Engl J Med       Date:  1990-09-06       Impact factor: 91.245

2.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

3.  Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities.

Authors:  C A Rouzer; T Matsumoto; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

4.  Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS.

Authors:  A H Stephenson; A J Lonigro; T M Hyers; R O Webster; A A Fowler
Journal:  Am Rev Respir Dis       Date:  1988-09

5.  Endogenous production of superoxide by rabbit lungs: effects of hypoxia or metabolic inhibitors.

Authors:  A Paky; J R Michael; T M Burke-Wolin; M S Wolin; G H Gurtner
Journal:  J Appl Physiol (1985)       Date:  1993-06

6.  Purification to homogeneity and the N-terminal sequence of human leukotriene C4 synthase: a homodimeric glutathione S-transferase composed of 18-kDa subunits.

Authors:  D W Nicholson; A Ali; J P Vaillancourt; J R Calaycay; R A Mumford; R J Zamboni; A W Ford-Hutchinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Time course of hypoxic pulmonary vasoconstriction after endotoxin infusion in unanesthetized sheep.

Authors:  J L Theissen; H M Loick; B B Curry; L D Traber; D N Herndon; D L Traber
Journal:  J Appl Physiol (1985)       Date:  1991-05

8.  Purification and characterisation of leukotriene A4 hydrolase from rat neutrophils.

Authors:  J F Evans; P Dupuis; A W Ford-Hutchinson
Journal:  Biochim Biophys Acta       Date:  1985-05-29

9.  Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.

Authors:  R A Dixon; R E Diehl; E Opas; E Rands; P J Vickers; J F Evans; J W Gillard; D K Miller
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

10.  Pulmonary and systemic vascular responsiveness to TNF-alpha in conscious rats.

Authors:  T Stevens; K Morris; I F McMurtry; M Zamora; A Tucker
Journal:  J Appl Physiol (1985)       Date:  1993-04
View more
  3 in total

1.  Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.

Authors:  Martin Wepler; Arkadi Beloiartsev; Mary D Buswell; Dipak Panigrahy; Rajeev Malhotra; Emmanuel S Buys; Peter Radermacher; Fumito Ichinose; Donald B Bloch; Warren M Zapol
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-11-04       Impact factor: 5.464

2.  5-Lipoxygenase activating protein (FLAP) dependent leukotriene biosynthesis inhibition (MK591) attenuates Lipid A endotoxin-induced inflammation.

Authors:  Wen-Feng Fang; Ivor S Douglas; Chin-Chou Wang; Hsu-Ching Kao; Ya-Ting Chang; Chia-Cheng Tseng; Kuo-Tung Huang; Huang-Chih Chang; Meng-Chih Lin
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

3.  Impaired hypoxic pulmonary vasoconstriction in a mouse model of Leigh syndrome.

Authors:  Grigorij Schleifer; Eizo Marutani; Michele Ferrari; Rohit Sharma; Owen Skinner; Olga Goldberger; Robert Matthew Henry Grange; Kathryn Peneyra; Rajeev Malhotra; Martin Wepler; Fumito Ichinose; Donald B Bloch; Vamsi K Mootha; Warren M Zapol
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-12-06       Impact factor: 5.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.